Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial

• Main Authors: Enikö Sonkoly (Author), Julia-Tatjana Maul (Author), Matteo Megna (Author), Patricia Gorecki (Author), Edmée Crombag (Author), Jozefien Buyze (Author), Laura Savage (Author)
• Format: Book
• Published: Medical Journals Sweden, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Scalp psoriasis affects approximately 80% of patients with psoriasis and can negatively impact their quality of life. This post hoc analysis of the VOYAGE 2 Phase III randomized clinical trial evaluated scalp response to guselkumab treatment and its association with skin response and patient-reporte...